Similar articles for PMID: 24811015

Year	Number of Results
1932	1
1945	1
1951	1
1962	1
1988	1
1992	1
1998	1
2000	1
2001	1
2006	1
2007	2
2008	8
2009	7
2010	4
2011	9
2012	13
2013	30
2014	25
2015	12
2016	4
2017	4
2018	6
2019	9
2020	8
2021	7
2022	5
2023	2
2024	0

1

Omalizumab as a desensitizing agent and treatment in mastocytosis: a review of the literature and case report.

Sokol KC, Ghazi A, Kelly BC, Grant JA. Sokol KC, et al. J Allergy Clin Immunol Pract. 2014 May-Jun;2(3):266-70. doi: 10.1016/j.jaip.2014.03.009. J Allergy Clin Immunol Pract. 2014. PMID: 24811015 Review.

2

Mastocytosis and insect venom allergy.

Bonadonna P, Zanotti R, Müller U. Bonadonna P, et al. Curr Opin Allergy Clin Immunol. 2010 Aug;10(4):347-53. doi: 10.1097/ACI.0b013e32833b280c. Curr Opin Allergy Clin Immunol. 2010. PMID: 20485157 Review.

3

Omalizumab mitigates anaphylaxis during ultrarush honey bee venom immunotherapy in monoclonal mast cell activation syndrome.

da Silva EN, Randall KL. da Silva EN, et al. J Allergy Clin Immunol Pract. 2013 Nov-Dec;1(6):687-8. doi: 10.1016/j.jaip.2013.07.004. Epub 2013 Sep 8. J Allergy Clin Immunol Pract. 2013. PMID: 24565720 No abstract available.

4

Unpredicted adverse reaction to omalizumab.

Jandus P, Hausmann O, Haeberli G, Gentinetta T, Mueller U, Helbling A. Jandus P, et al. J Investig Allergol Clin Immunol. 2011;21(7):563-6. J Investig Allergol Clin Immunol. 2011. PMID: 22312942 Free article.

5

Treatment with a combination of omalizumab and specific immunotherapy for severe anaphylaxis after a wasp sting.

Palgan K, Bartuzi Z, Gotz-Zbikowska M. Palgan K, et al. Int J Immunopathol Pharmacol. 2014 Jan-Mar;27(1):109-12. doi: 10.1177/039463201402700114. Int J Immunopathol Pharmacol. 2014. PMID: 24674685 Free article.

6

Successful treatment of mastocytic anaphylactic episodes with reduction of skin mast cells after anti-IgE therapy.

Paraskevopoulos G, Sifnaios E, Christodoulopoulos K, Mantopoulou F, Papakonstantis M, Sabaziotis D. Paraskevopoulos G, et al. Eur Ann Allergy Clin Immunol. 2013 Apr;45(2):52-5. Eur Ann Allergy Clin Immunol. 2013. PMID: 23821833

7

Omalizumab and hypersensitivity reactions.

Shankar T, Petrov AA. Shankar T, et al. Curr Opin Allergy Clin Immunol. 2013 Feb;13(1):19-24. doi: 10.1097/ACI.0b013e32835bf3f5. Curr Opin Allergy Clin Immunol. 2013. PMID: 23242113 Review.

8

Potential treatments for food allergy.

Albin S, Nowak-Węgrzyn A. Albin S, et al. Immunol Allergy Clin North Am. 2015 Feb;35(1):77-100. doi: 10.1016/j.iac.2014.09.011. Epub 2014 Nov 21. Immunol Allergy Clin North Am. 2015. PMID: 25459578 Review.

9

Severe anaphylaxis to bee venom immunotherapy: efficacy of pretreatment and concurrent treatment with omalizumab.

Galera C, Soohun N, Zankar N, Caimmi S, Gallen C, Demoly P. Galera C, et al. J Investig Allergol Clin Immunol. 2009;19(3):225-9. J Investig Allergol Clin Immunol. 2009. PMID: 19610266 Free article.

10

Mastocytosis and Hymenoptera venom allergy.

Ruëff F, Placzek M, Przybilla B. Ruëff F, et al. Curr Opin Allergy Clin Immunol. 2006 Aug;6(4):284-8. doi: 10.1097/01.all.0000235903.10548.63. Curr Opin Allergy Clin Immunol. 2006. PMID: 16825870 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

147 results

Results by year